Literature DB >> 31846062

Hepatitis A immunisation in persons not previously exposed to hepatitis A.

Greg J Irving1, John Holden2, Rongrong Yang3, Daniel Pope4.   

Abstract

This review is withdrawn because it is outdated. A new review is to be published by the end of 2019.
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Entities:  

Year:  2019        PMID： 31846062      PMCID： PMC6916710          DOI： 10.1002/14651858.CD009051.pub3

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN： 1361-6137


  155 in total

Review 1.  New technology platforms in the development of vaccines for the future.

Authors:  R Glück; I C Metcalfe
Journal:  Vaccine       Date:  2002-12-20       Impact factor: 3.641

2.  [Immunogenicity and efficacy of two live attenuated hepatitis A vaccines (H(2) strains and LA-1 strains)].

Authors:  Zhiyi Xu; Xuanyi Wang; Rongcheng Li; Zongda Meng; Yong Zhang; Jian Gong; Jingchen Ma; Yanting Li; Shoujun Zhao; Yanping Li; Yuliang Zhao; Quancheng Huang; Dong Luo; Jianling Xia; Hongbin Liu; Xinli Liu; Peiying Ouyang
Journal:  Zhonghua Yi Xue Za Zhi       Date:  2002-05-25

3.  Cell mediated and antibody immune response to inactivated hepatitis A vaccine.

Authors:  P Schmidtke; P Habermehl; M Knuf; C U Meyer; R Sänger; F Zepp
Journal:  Vaccine       Date:  2005-10-25       Impact factor: 3.641

4.  Immunogenicity and safety of a new inactivated hepatitis A vaccine in a comparative study.

Authors:  C Goilav; J Zuckerman; M Lafrenz; E Vidor; S Lauwers; C Ratheau; G Benichou; A Zuckerman
Journal:  J Med Virol       Date:  1995-07       Impact factor: 2.327

5.  Safety and immunogenicity of an inactivated hepatitis A vaccine: effect of dose and vaccination schedule.

Authors:  T U Westblom; S Gudipati; C DeRousse; B R Midkiff; R B Belshe
Journal:  J Infect Dis       Date:  1994-05       Impact factor: 5.226

6.  [Primary study on immunologic effect of live attenuated hepatitis A vaccine (H2 strain) after booster dose].

Authors:  X Wang; J Ma; Y Zhang; Y Zhang; C Han; Z Xing; J Chen; Y Zhang; S Zhao; H Gu; Z Xu
Journal:  Zhonghua Liu Xing Bing Xue Za Zhi       Date:  2000-04

7.  Influence of human immunodeficiency virus type 1 infection on acute hepatitis A virus infection.

Authors:  Setsuko Ida; Natsuo Tachikawa; Aya Nakajima; Manabu Daikoku; Michitami Yano; Yoshimi Kikuchi; Akira Yasuoka; Satoshi Kimura; Shinichi Oka
Journal:  Clin Infect Dis       Date:  2001-12-14       Impact factor: 9.079

Review 8.  Hepatology may have problems with putative surrogate outcome measures.

Authors:  Christian Gluud; Jesper Brok; Yan Gong; Ronald L Koretz
Journal:  J Hepatol       Date:  2007-01-26       Impact factor: 25.083

9.  Efficacy of virosome hepatitis A vaccine in young children in Nicaragua: randomized placebo-controlled trial.

Authors:  Orlando Mayorga Pérez; Christian Herzog; Martina Zellmeyer; Arnoldo Loáisiga; Gert Frösner; Matthias Egger
Journal:  J Infect Dis       Date:  2003-08-11       Impact factor: 5.226

10.  Safety and immunogenicity of live attenuated hepatitis A virus vaccine (H2 strain) in humans.

Authors:  L A Ran; D Z Wang; Q Y Duan; T Y Yan; Q L Liu; Y G Luo; D Z Yang; D F Yang; Z Xiao; Q J Xie
Journal:  Chin Med J (Engl)       Date:  1993-08       Impact factor: 2.628
View more
  1 in total

1.  Eliminating viral hepatitis in children after liver transplants: How to reach the goal by 2030.

Authors:  Palittiya Sintusek; Kessarin Thanapirom; Piyawat Komolmit; Yong Poovorawan
Journal:  World J Gastroenterol       Date:  2022-01-21       Impact factor: 5.742
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.